Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Balkau

Showing results (41-50 of 205) with videos related to

Pageof 21
Sort By:
Public Health|December 10, 2016
Metabolic syndrome in adolescents: definition based on regression of IDF adult cut-off pointsK Benmohammed, P Valensi, B Balkau, et al.
Diabetes Care|May 20, 1999
Is there a glycemic threshold for mortality risk?B Balkau, S Bertrais, P Ducimetiere, et al.
American Journal of Epidemiology|December 15, 1991
Re: "A prospective population-based study of alcohol use and non-insulin-dependent diabetes mellitus"B Balkau, A Randrianjohany, L Papoz, et al.
Diabetes & Metabolism|January 7, 1998
Proposed criteria for the diagnosis of diabetes: evidence from a French epidemiological study (D.E.S.I.R.)B Balkau, E Eschwege, J Tichet, et al.
Diabetes & Metabolism|April 16, 1998
[Revision of diagnostic criteria of diabetes. The reasons and the consequences]M A Charles, D Simon, B Balkau, et al.
Journal of Hepatology|April 6, 1999
Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC GroupR Poupon, O Chazouillères, B Balkau, et al.
American Journal of Epidemiology|October 1, 1985
Factors associated with the development of diabetes in the Micronesian population of NauruB Balkau, H King, P Zimmet, et al.
Diabetes|January 1, 1994
Maternal effect and familial aggregation in NIDDM. The CODIAB Study. CODIAB-INSERM-ZENECA Study GroupF Thomas, B Balkau, F Vauzelle-Kervroedan, et al.
Hepatology (Baltimore, Md.)|March 1, 1994
Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissueR E Poupon, B Balkau, J Guéchot, et al.
The New England Journal of Medicine|May 30, 1991
A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study GroupR E Poupon, B Balkau, E Eschwège, et al.
Pageof 21

Showing results (41-50 of 205) with videos related to

Sort By:
Pageof 21
Public Health|December 10, 2016
Metabolic syndrome in adolescents: definition based on regression of IDF adult cut-off pointsK Benmohammed, P Valensi, B Balkau, et al.
Diabetes Care|May 20, 1999
Is there a glycemic threshold for mortality risk?B Balkau, S Bertrais, P Ducimetiere, et al.
American Journal of Epidemiology|December 15, 1991
Re: "A prospective population-based study of alcohol use and non-insulin-dependent diabetes mellitus"B Balkau, A Randrianjohany, L Papoz, et al.
Diabetes & Metabolism|January 7, 1998
Proposed criteria for the diagnosis of diabetes: evidence from a French epidemiological study (D.E.S.I.R.)B Balkau, E Eschwege, J Tichet, et al.
Diabetes & Metabolism|April 16, 1998
[Revision of diagnostic criteria of diabetes. The reasons and the consequences]M A Charles, D Simon, B Balkau, et al.
Journal of Hepatology|April 6, 1999
Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC GroupR Poupon, O Chazouillères, B Balkau, et al.
American Journal of Epidemiology|October 1, 1985
Factors associated with the development of diabetes in the Micronesian population of NauruB Balkau, H King, P Zimmet, et al.
Diabetes|January 1, 1994
Maternal effect and familial aggregation in NIDDM. The CODIAB Study. CODIAB-INSERM-ZENECA Study GroupF Thomas, B Balkau, F Vauzelle-Kervroedan, et al.
Hepatology (Baltimore, Md.)|March 1, 1994
Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissueR E Poupon, B Balkau, J Guéchot, et al.
The New England Journal of Medicine|May 30, 1991
A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study GroupR E Poupon, B Balkau, E Eschwège, et al.
Pageof 21